BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20140680)

  • 1. In vitro interactions between aged garlic extract and drugs used for the treatment of cardiovascular and diabetic patients.
    Berginc K; Žakelj S; Kristl A
    Eur J Nutr; 2010 Sep; 49(6):373-84. PubMed ID: 20140680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanisms responsible for garlic - drug interactions and their in vivo relevance.
    Berginc K; Kristl A
    Curr Drug Metab; 2013 Jan; 14(1):90-101. PubMed ID: 21838705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV protease inhibitors: garlic supplements and first-pass intestinal metabolism impact on the therapeutic efficacy.
    Berginc K; Trdan T; Trontelj J; Kristl A
    Biopharm Drug Dispos; 2010 Nov; 31(8-9):495-505. PubMed ID: 21104925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aged garlic extract stimulates p-glycoprotein and multidrug resistance associated protein 2 mediated effluxes.
    Berginc K; Zakelj S; Ursic D; Kristl A
    Biol Pharm Bull; 2009 Apr; 32(4):694-9. PubMed ID: 19336907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1.
    Luo FR; Paranjpe PV; Guo A; Rubin E; Sinko P
    Drug Metab Dispos; 2002 Jul; 30(7):763-70. PubMed ID: 12065434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
    Guo A; Marinaro W; Hu P; Sinko PJ
    Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems.
    Takusagawa S; Ushigome F; Nemoto H; Takahashi Y; Li Q; Kerbusch V; Miyashita A; Iwatsubo T; Usui T
    Mol Pharm; 2013 May; 10(5):1783-94. PubMed ID: 23560393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug-drug interactions.
    Kis O; Zastre JA; Hoque MT; Walmsley SL; Bendayan R
    Pharm Res; 2013 Apr; 30(4):1050-64. PubMed ID: 23224979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of aged garlic extract on the uptake of saquinavir and darunavir into HepG2 cells and rat liver slices.
    Berginc K; Trontelj J; Kristl A
    Drug Metab Pharmacokinet; 2010; 25(3):307-13. PubMed ID: 20610890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
    Dahan A; Amidon GL
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal absorption mechanisms of 2'-deoxy-2'-β-fluoro-4'-azidocytidine, a cytidine analog for AIDS treatment, and its interaction with P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein.
    Liu Y; Liu B; Zhang Y; Peng Y; Huang C; Wang N; Jiang J; Wang Q; Chang J
    Eur J Pharm Sci; 2017 Jul; 105():150-158. PubMed ID: 28487144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transepithelial transport mechanisms of 7,8-dihydroxyflavone, a small molecular TrkB receptor agonist, in human intestinal Caco-2 cells.
    Chen Y; Xue F; Xia G; Zhao Z; Chen C; Li Y; Zhang Y
    Food Funct; 2019 Aug; 10(8):5215-5227. PubMed ID: 31384856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
    Dahan A; Sabit H; Amidon GL
    Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.
    Makhey VD; Guo A; Norris DA; Hu P; Yan J; Sinko PJ
    Pharm Res; 1998 Aug; 15(8):1160-7. PubMed ID: 9706044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transwell-grown HepG2 cell monolayers as in vitro permeability model to study drug-drug or drug-food interactions.
    Berginc K; Kristl A
    J Med Food; 2011; 14(1-2):135-9. PubMed ID: 21138349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular Metabolomics Identifies Efflux Transporter Inhibitors in a Routine Caco-2 Cell Permeability Assay-Biological Implications.
    Naseem A; Pal A; Gowan S; Asad Y; Donovan A; Temesszentandrási-Ambrus C; Kis E; Gaborik Z; Bhalay G; Raynaud F
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescein transport properties across artificial lipid membranes, Caco-2 cell monolayers and rat jejunum.
    Berginc K; Zakelj S; Levstik L; Ursic D; Kristl A
    Eur J Pharm Biopharm; 2007 May; 66(2):281-5. PubMed ID: 17129714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
    Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and better protocols for a short-term Caco-2 cell culture system.
    Yamashita S; Konishi K; Yamazaki Y; Taki Y; Sakane T; Sezaki H; Furuyama Y
    J Pharm Sci; 2002 Mar; 91(3):669-79. PubMed ID: 11920752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Garlic flavonoids and organosulfur compounds: impact on the hepatic pharmacokinetics of saquinavir and darunavir.
    Berginc K; Milisav I; Kristl A
    Drug Metab Pharmacokinet; 2010; 25(6):521-30. PubMed ID: 20930421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.